NEW YORK, June 25, 2018 /PRNewswire/ --
According to a research reportprovided by Marijuana Business Daily, cannabis retail sales continue to grow year-over-year, as new markets emerge, and more states legalize medical and recreational cannabis. Sales in 2018 are expected to surge by approximately 50% when compared to
Legalization movements are currently succeeding in changing policies beyond the U.S. region. Canada has passed a nationwide legalization of recreational cannabis usage on June 19th, 2018, the second nation to do so after Uruguay. As for the U.S., the process of cannabis legalization for the majority of the West Coast states has already begun, while almost all states have medical use legalized to an extent. And while California is the largest market, Canada is projected to show strong sales as well; Deloitte's report projects the Canadian market will be worth at least USD 5 Billion in sales in 2018.
GreenTec Holdings Ltd. (TSX-V: GTEC) is listed on the TSX Venture Exchange under the ticker ("GTEC"). Just earlier today, the company announced breaking news that it, "is pleased to provide an update on the operations of its wholly owned subsidiaries. On June 19, 2018 the Canadian Senate passed a bill that will legalize recreational cannabis nationally. Canada is only the second country in the world - and the first G7 nation - to legalize recreational cannabis. The following day, Prime Minister Justin Trudeau announced that Canadians will be able to legally consume cannabis recreationally commencing October 17, 2018. These timelines dovetail very well with the development of GreenTec's cultivation and lab facilities:
Norton Singhavon, Chairman & CEO of GTEC Holdings, provided the following comments: "We are very excited about recent developments facilitating legalization of recreational cannabis on October 17th. We anticipate that we will have significant cultivation capacity in place by this date. Accordingly, we are confident that we are well positioned to become one of the leading vertically integrated craft cannabis companies in Canada"."
Aurora Cannabis Inc. (OTCQX: ACBFF) is a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations. Aurora Cannabis Inc. and Anandia Laboratories Inc. recently announced that they have signed a binding term sheet whereby Aurora intends to acquire all of the issued and outstanding common shares of privately-held Anandia in an all share transaction valued at approximately USD 115 Million on a fully diluted basis. Anandia's intellectual property includes the exclusive rights to a number of key genes in the cannabinoid pathway, as well as patents pending for genetic markers. The strength of Anandia's expert staff, proprietary assets and know-how will provide Aurora with a very significant advantage in developing new cannabis cultivars. For instance, genome-based variety development and technological fortification can tailor metabolite (cannabinoid and terpene) profiles, improve disease resistance, enhance crop yield and optimize flowering time, and can be employed to develop specialized cultivars for oil production. Combining with Aurora gives Anandia access to significant new market opportunities in Canada and internationally through Aurora's global footprint, according to the Company. "The Transaction will greatly boost our competitive advantage in developing marketable intellectual property and high-margin products and help address diversified needs on a global basis," concluded Neil Belot, Chief Global Business Development Officer for Aurora.
Auxly Cannabis Group Inc. (OTCQB: CBWTF) is a collective of entrepreneurs with a passion for the cannabis industry past, present and future. The Company recently announced that further to its previously announced transaction on February 16, 2018, the Company has entered into a definitive joint venture agreement with Peter Quiring, one of Canada's largest greenhouse builders and operators, to develop, construct and operate a fully-automated, state-of-the-art, purpose-built greenhouse for cannabis cultivation in Leamington, Ontario. Hugo Alves, President of Auxly, stated, "The combination of being the largest builder of greenhouses in Canada and the experience of operating 175 acres of greenhouses in Canada and the United States, truly places Peter in a league of his own. As a cornerstone partnership in the Auxly platform, JVco is a unique opportunity to achieve large-scale, low cost production of cannabis with one of North America's premier greenhouse operators. Upon completion, this upstream project will be a significant source of product into our midstream value-add and downstream distribution channels. We look forward to building a state-of-the art facility with Peter and his team and a long and successful business partnership."
Supreme Cannabis Company Inc. (OTC: SPRWF) is a Canadian publicly traded company committed to becoming a leading cultivator and distributor of sun grown cannabis through its wholly-owned subsidiary 7ACRES. 7ACRES is a federally licensed producer of medical cannabis pursuant to the ACMPR operating inside a 342,000 sq. ft. Hybrid Facility. The Company recently announced that it has entered into a definitive agreement pursuant to which Supreme Cannabis will complete a CAD 10,000,000 strategic equity investment in Medigrow. Upon completion of the Investment, Supreme Cannabis will hold an approximate 10% ownership interest in Medigrow. Supreme Cannabis expects strong demand to exceed supply for medical cannabis oil globally and believes Lesotho is well suited to produce quality cannabis oil, while Medigrow possesses the expertise to meet the highest quality standards. Concurrent with the completion of the Investment, Supreme Cannabis and Medigrow have agreed to enter into a long-term global distribution partnership for medical cannabis oil.
Namaste Technologies Inc. (OTCQB: NXTTF) is a global leader in the sale of medical cannabis consumption devices. The Company recently announced that, further to its January 18th, 2018 letter of intent, that the Company has signed a subscription agreement to acquire 10% of the issued share capital of Israeli licensed producer of medical cannabis, Cannbit Ltd for NIS 2,500,000 or approximately CAD 908,000, which includes a combination of both cash and shares. Subsequently, Cannbit has also signed a binding agreement to complete a merger with a company listed on the Tel Aviv stock exchange, whereby Cannbit will retain 85% ownership of the combined public entity. The Company believes that its investment will be immediately accretive in nature based on the valuation metrics of the transaction which consequently valued Cannbit significantly higher than what Namaste acquired its 10% equity stake for. In anticipation of closing this transaction, Namaste has established a supply arrangement with Cannbit to export cannabis to the Canadian market and will also engage with Cannbit to expand the Company's Israeli-based vaporizer sales platform.
Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.
Media Contact: email@example.com +1-877-601-1879
Subscribe to our Free Newsletters!
Take the quiz on Rabies and test your knowledge about this infection that can affect the brain ...
Pneumonitis usually refers to inflammation of lung tissue due to various non-infective causes such ...
Fremanezumab-vfrm is used as a preventive treatment for a migraine headache in adult patients. It ...View All